Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Higher Radiation Dose in Patients and Operators with Radial Approach (RAD-MATRIX Dosimeter)

Radiation Dose in Patients and Operators with Radial ApproachBoth physicians and patients are exposed to higher radiation doses during radial access PCI compared to femoral, according to this large contemporary study on high volume PCI operators of ACS patients.

 

Even though the difference in radiation exposure was relatively small for patients (approximately 10% higher for radial PCI) this translated into double the exposure to operators’ thorax.

 

For every 100 femoral procedures, operators receive doses equivalent to 6 chest x-rays, while for every 100 radial procedures, doses equal 11.5 x-rays.

 

The RAD-MATRIX was a substudy of the MATRIX trial, which randomized over 8,400 ACS patients with or without STEMI to radial or femoral PCI between October 2011 and November 2014. The substudy focused on 18 operators who collectively performed 777 of those procedures (398 radial).

.

Operators wore dedicated dosimeters on their left wrist, at mid-chest outside the protective lead apron, and at head level, to measure eye exposure. Additionally, all operators used standard protection, which included a screen fixed to the PCI table to protect their lower body and a mobile screen suspended from the roof to protect their upper body.

 

Chest, head and wrist doses were similar when comparing left and right radial access sites.

 

According to the study, the incremental operator effective dose for a single radial vs. femoral procedure is about 1.1 μSv. Extrapolated over 300 procedures, this corresponds to additional 330 μSv, or the equivalent of 17 additional chest X-rays.

 

The RAD-MATRIX outcomes contradict a recent meta-analyzis that suggests radiation exposure decreases over time, as operators’ experience increases.

 

The difference observed in this study was seen in highly experienced radial access operators, which is why we would expect even more significant differences in less experienced operators.

 

The difference in bleeding and vascular complications justifies, without question, the slightly higher patient exposure. As regards physicians, we should continue to use the radial approach as often, but with caution, taking all the necessary protection measures available.

 

Original Title: Radiation exposure and vascular access in acute coronary syndromes: The RADMatrix Trial. J Am Coll Cardiol. 2017; Epub ahead of print.

Presenter: Alessandro Sciahbasi.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...